BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1452 related articles for article (PubMed ID: 30360400)

  • 1. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.
    Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the Multivalency of Ultrashort Arg-Trp-Based Antimicrobial Peptides (AMP) on Their Antibacterial Activity.
    Hoffknecht BC; Worm DJ; Bobersky S; Prochnow P; Bandow JE; Metzler-Nolte N
    ChemMedChem; 2015 Sep; 10(9):1564-9. PubMed ID: 26149664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Potent Antibacterial Organometallic Peptide Conjugates.
    Albada B; Metzler-Nolte N
    Acc Chem Res; 2017 Oct; 50(10):2510-2518. PubMed ID: 28953347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of short hydrophobic and basic-rich peptides.
    Chen PW; Shyu CL; Mao FC
    Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
    Cruz J; Rondon-Villarreal P; Torres RG; Urquiza M; Guzman F; Alvarez C; Abengozar MA; Sierra DA; Rivas L; Fernandez-Lafuente R; Ortiz CC
    Med Chem; 2018; 14(7):741-752. PubMed ID: 29737262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.
    Hicks RP
    Bioorg Med Chem; 2016 Sep; 24(18):4056-4065. PubMed ID: 27387357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum activity of membranolytic cationic macrocyclic peptides against multi-drug resistant bacteria and fungi.
    Lohan S; Konshina AG; Tiwari RK; Efremov RG; Maslennikov I; Parang K
    Eur J Pharm Sci; 2024 Jun; 197():106776. PubMed ID: 38663759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.
    Monroc S; Badosa E; Feliu L; Planas M; Montesinos E; Bardají E
    Peptides; 2006 Nov; 27(11):2567-74. PubMed ID: 16730857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo cyclic pseudopeptides containing aza-β3-amino acids exhibiting antimicrobial activities.
    Laurencin M; Amor M; Fleury Y; Baudy-Floc'h M
    J Med Chem; 2012 Dec; 55(24):10885-95. PubMed ID: 23148564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel designed VmCT1 analogs with increased antimicrobial activity.
    Pedron CN; Torres MT; Lima JADS; Silva PI; Silva FD; Oliveira VX
    Eur J Med Chem; 2017 Jan; 126():456-463. PubMed ID: 27912176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.
    Lin MC; Hui CF; Chen JY; Wu JL
    Peptides; 2013 Jun; 44():139-48. PubMed ID: 23598079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens.
    Jiang Z; Mant CT; Vasil M; Hodges RS
    Chem Biol Drug Des; 2018 Jan; 91(1):75-92. PubMed ID: 28636788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
    Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
    FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, conformational analysis and biological studies of cyclic cationic antimicrobial peptides containing sugar amino acids.
    Chakraborty TK; Koley D; Ravi R; Krishnakumari V; Nagaraj R; Kunwar AC
    J Org Chem; 2008 Nov; 73(22):8731-44. PubMed ID: 18937406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt-resistant short antimicrobial peptides.
    Mohanram H; Bhattacharjya S
    Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility.
    Saravanan R; Li X; Lim K; Mohanram H; Peng L; Mishra B; Basu A; Lee JM; Bhattacharjya S; Leong SS
    Biotechnol Bioeng; 2014 Jan; 111(1):37-49. PubMed ID: 23860860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
    Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
    J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
    Mai XT; Huang J; Tan J; Huang Y; Chen Y
    J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.